Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market for diabetes-associated ophthalmic.
This report contains market size and forecasts of Diabetes Associated Ophthalmic Treatment in Global, including the following market information:
Global Diabetes Associated Ophthalmic Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Associated Ophthalmic Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry Eye Syndrome Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Associated Ophthalmic Treatment include Alcon, Johnson & Johnson Services, Inc., Bausch Health, F. Hoffmann-La Roche Ltd, Allergan, Bayer AG, Santen Pharmaceutical Co. Ltd., Novartis AG and Pfizer, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Associated Ophthalmic Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Associated Ophthalmic Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by Type, 2021 (%)
Dry Eye Syndrome
Glaucoma
Eye Allergy & Infection
Diabetic Retinopathy
Diabetic associated Macular Degeneration
Uveitis
Cataract
Diabetic Macular Edema
Others
Global Diabetes Associated Ophthalmic Treatment Market, by End User, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by End User, 2021 (%)
Hospitals
Ophthalmic Centers
Ambulatory Surgical Centers
Others
Global Diabetes Associated Ophthalmic Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Associated Ophthalmic Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Associated Ophthalmic Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
Johnson & Johnson Services, Inc.
Bausch Health
F. Hoffmann-La Roche Ltd
Allergan
Bayer AG
Santen Pharmaceutical Co. Ltd.
Novartis AG
Pfizer, Inc.
Genentech, Inc.
Carl Zeiss Meditec
Lumenis
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Topcon Corp.
Abbott Medical Optics
Quantel